160 related articles for article (PubMed ID: 22607473)
21. X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP.
Sivaraman KK; Oellig CA; Huynh K; Atkinson SC; Poreba M; Perugini MA; Trenholme KR; Gardiner DL; Salvesen G; Drag M; Dalton JP; Whisstock JC; McGowan S
J Mol Biol; 2012 Sep; 422(4):495-507. PubMed ID: 22709581
[TBL] [Abstract][Full Text] [Related]
22. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
Dali B; Keita M; Megnassan E; Frecer V; Miertus S
Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
[TBL] [Abstract][Full Text] [Related]
23. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
24. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
[TBL] [Abstract][Full Text] [Related]
25. Glyoxalase pathway of trypanosomatid parasites: a promising chemotherapeutic target.
Chauhan SC; Padmanabhan PK; Madhubala R
Curr Drug Targets; 2008 Nov; 9(11):957-65. PubMed ID: 18991608
[TBL] [Abstract][Full Text] [Related]
26. Entropy effects on protein hinges: the reaction catalyzed by triosephosphate isomerase.
Xiang J; Jung JY; Sampson NS
Biochemistry; 2004 Sep; 43(36):11436-45. PubMed ID: 15350130
[TBL] [Abstract][Full Text] [Related]
27. Glutathione transferase from Plasmodium falciparum--interaction with malagashanine and selected plant natural products.
Mangoyi R; Hayeshi R; Ngadjui B; Ngandeu F; Bezabih M; Abegaz B; Razafimahefa S; Rasoanaivo P; Mukanganyama S
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):854-62. PubMed ID: 20521884
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium's sticky fingers.
Waters AP
Cell; 2005 Jul; 122(2):149-51. PubMed ID: 16051139
[TBL] [Abstract][Full Text] [Related]
29. Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I.
Takasawa R; Saeki K; Tao A; Yoshimori A; Uchiro H; Fujiwara M; Tanuma S
Bioorg Med Chem; 2010 Oct; 18(19):7029-33. PubMed ID: 20801663
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of Plasmodium falciparum cysteine protease, falcipain-2B.
Jeong JJ; Kumar A; Hanada T; Seo PS; Li X; Hanspal M; Chishti AH
Blood Cells Mol Dis; 2006; 36(3):429-35. PubMed ID: 16595182
[TBL] [Abstract][Full Text] [Related]
31. Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum.
Geist JG; Lauw S; Illarionova V; Illarionov B; Fischer M; Gräwert T; Rohdich F; Eisenreich W; Kaiser J; Groll M; Scheurer C; Wittlin S; Alonso-Gómez JL; Schweizer WB; Bacher A; Diederich F
ChemMedChem; 2010 Jul; 5(7):1092-101. PubMed ID: 20480490
[TBL] [Abstract][Full Text] [Related]
32. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.
Česnek M; Hocková D; Holý A; Dračínský M; Baszczyňski O; Jersey Jd; Keough DT; Guddat LW
Bioorg Med Chem; 2012 Jan; 20(2):1076-89. PubMed ID: 22178188
[TBL] [Abstract][Full Text] [Related]
34. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.
Krungkrai SR; Aoki S; Palacpac NM; Sato D; Mitamura T; Krungkrai J; Horii T
Mol Biochem Parasitol; 2004 Apr; 134(2):245-55. PubMed ID: 15003844
[TBL] [Abstract][Full Text] [Related]
35. Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug.
Padmanabhan PK; Mukherjee A; Singh S; Chattopadhyaya S; Gowri VS; Myler PJ; Srinivasan N; Madhubala R
Biochem Biophys Res Commun; 2005 Dec; 337(4):1237-48. PubMed ID: 16236261
[TBL] [Abstract][Full Text] [Related]
36. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
37. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids.
Degliesposti G; Kasam V; Da Costa A; Kang HK; Kim N; Kim DW; Breton V; Kim D; Rastelli G
ChemMedChem; 2009 Jul; 4(7):1164-73. PubMed ID: 19437467
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum.
Wrenger C; Müller IB; Schifferdecker AJ; Jain R; Jordanova R; Groves MR
J Mol Biol; 2011 Jan; 405(4):956-71. PubMed ID: 21087616
[TBL] [Abstract][Full Text] [Related]
39. Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.
Liu P; Marzahn MR; Robbins AH; Gutiérrez-de-Terán H; Rodríguez D; McClung SH; Stevens SM; Yowell CA; Dame JB; McKenna R; Dunn BM
Biochemistry; 2009 May; 48(19):4086-99. PubMed ID: 19271776
[TBL] [Abstract][Full Text] [Related]
40. Glyoxalase biochemistry.
Honek JF
Biomol Concepts; 2015 Dec; 6(5-6):401-14. PubMed ID: 26552067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
